LRI Investments’s LeMaitre Vascular LMAT Stock Holding History

LRI Investments’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4K	Sell	25 -16	-39%	-$1.64K	﹤0.01%	1253
2026 Q1	$4.48K	Hold	41	–	–	﹤0.01%	1124
2025 Q4	$3.36K	Hold	41	–	–	﹤0.01%	1114
2025 Q3	$3.63K	Sell	41 -7	-15%	-$625	﹤0.01%	1103
2025 Q2	$4.02K	Hold	48	–	–	﹤0.01%	1068
2025 Q1	$4.06K	Buy	48 +5	+12%	+$465	﹤0.01%	996
2024 Q4	$3.94K	Hold	43	–	–	﹤0.01%	980
2024 Q3	$4.34K	Buy	43 +14	+48%	+$1.21K	﹤0.01%	962
2024 Q2	$2.35K	Buy	+29	New	+$2.13K	﹤0.01%	1033

Other funds holding LMAT

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

CCG

Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PWG

Portside Wealth Group Provo, Utah $858M AUM 26.82% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

LRI Investments's LMAT Position: Q2 2026 in Review

LRI Investments reduced its LeMaitre Vascular (LMAT) stake by 39% in Q2 2026, selling an estimated $1.64K and leaving 25 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

LRI Investments first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.48K in Q1 2026. 32 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

LRI Investments held 25 shares of LeMaitre Vascular worth $2.4K as of Q2 2026.
LRI Investments sold 16 LeMaitre Vascular shares in Q2 2026, an estimated $1.64K.
LeMaitre Vascular made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1253 holding.
LRI Investments first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
LRI Investments's LeMaitre Vascular position peaked at $4.48K in Q1 2026.
32 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.